###begin article-title 0
###xml 52 73 52 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 52 73 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo
###end article-title 0
###begin p 1
Conceived and designed the experiments: YCL PMS MJA CLF RM MLP. Performed the experiments: YCL PMS MJA CLF MMS MLP. Analyzed the data: YCL PMS MJA CLF MMS RM MLP. Contributed reagents/materials/analysis tools: PMS MLP. Wrote the paper: YCL PMS MJA CLF MMS RM MLP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 71 92 71 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 144 153 144 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 290 299 290 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 71 92 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 144 153 <span type="species:ncbi:1280">S. aureus</span>
###xml 290 299 <span type="species:ncbi:1280">S. aureus</span>
Glycerol monolaurate (GML), a 12 carbon fatty acid monoester, inhibits Staphylococcus aureus growth and exotoxin production, but is degraded by S. aureus lipase. Therefore, dodecylglycerol (DDG), a 12 carbon fatty acid monoether, was compared in vitro and in vivo to GML for its effects on S. aureus growth, exotoxin production, and stability.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 85 94 81 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 332 341 328 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 369 370 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 549 558 533 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 702 711 686 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 85 94 <span type="species:ncbi:1280">S. aureus</span>
###xml 208 214 <span type="species:ncbi:9986">rabbit</span>
###xml 332 341 <span type="species:ncbi:1280">S. aureus</span>
###xml 343 346 <span type="species:ncbi:1280">MN8</span>
###xml 549 558 <span type="species:ncbi:1280">S. aureus</span>
###xml 702 711 <span type="species:ncbi:1280">S. aureus</span>
###xml 762 769 <span type="species:ncbi:9986">rabbits</span>
###xml 815 822 <span type="species:ncbi:9986">rabbits</span>
Antimicrobial effects of GML and DDG (0 to 500 microg/ml) on 54 clinical isolates of S. aureus, including pulsed-field gel electrophoresis (PFGE) types USA200, USA300, and USA400, were determined in vitro. A rabbit Wiffle ball infection model assessed GML and DDG (1 mg/ml instilled into the Wiffle ball every other day) effects on S. aureus (MN8) growth (inoculum 3x108 CFU/ml), toxic shock syndrome toxin-1 (TSST-1) production, tumor necrosis factor-alpha (TNF-alpha) concentrations and mortality over 7 days. DDG (50 and 100 microg/ml) inhibited S. aureus growth in vitro more effectively than GML (p<0.01) and was stable to lipase degradation. Unlike GML, DDG inhibition of TSST-1 was dependent on S. aureus growth. GML-treated (4 of 5; 80%) and DDG-treated rabbits (2 of 5; 40%) survived after 7 days. Control rabbits (5 of 5; 100%) succumbed by day 4. GML suppressed TNF-alpha at the infection site on day 7; however, DDG did not (<10 ng/ml versus 80 ng/ml, respectively).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 73 82 73 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 232 241 228 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 449 458 445 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 42 51 <span type="species:ncbi:1280">S. aureus</span>
###xml 73 82 <span type="species:ncbi:1280">S. aureus</span>
###xml 232 241 <span type="species:ncbi:1280">S. aureus</span>
###xml 449 458 <span type="species:ncbi:1280">S. aureus</span>
These data suggest that DDG was stable to S. aureus lipase and inhibited S. aureus growth at lower concentrations than GML in vitro. However, in vivo GML was more effective than DDG by reducing mortality, and suppressing TNF-alpha, S. aureus growth and exotoxin production, which may reduce toxic shock syndrome. GML is proposed as a more effective anti-staphylococcal topical anti-infective candidate than DDG, despite its potential degradation by S. aureus lipase.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Gordon1">[1]</xref>
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Chuang1">[2]</xref>
###xml 195 204 195 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Gordon1">[1]</xref>
###xml 282 291 282 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 552 561 552 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 617 626 617 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 759 762 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Boguniewicz1">[3]</xref>
###xml 0 21 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 195 204 <span type="species:ncbi:1280">S. aureus</span>
###xml 260 266 <span type="species:ncbi:9606">People</span>
###xml 282 291 <span type="species:ncbi:1280">S. aureus</span>
###xml 464 470 <span type="species:ncbi:9606">People</span>
###xml 552 561 <span type="species:ncbi:1280">S. aureus</span>
###xml 617 626 <span type="species:ncbi:1280">S. aureus</span>
Staphylococcus aureus is an important cause of skin and mucosal infections both in hospital and community settings [1], [2]. Approximately 20% of the U.S. population is persistently colonized by S. aureus in the nose, and 30% are intermittently colonized [1]. People colonized with S. aureus are at higher risk of becoming infected by the organism, especially when host defenses are breached, for example, postsurgical wounds, catheter insertions, or burn wounds. People suffering from atopic dermatitis are more likely to be colonized and infected by S. aureus than the general population. Superantigens produced by S. aureus are known factors that enhance skin inflammation in atopic dermatitis and may be responsible for steroid resistant T cell responses [3].
###end p 9
###begin p 10
###xml 593 602 593 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Chuang1">[2]</xref>
###xml 655 658 655 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Jarman1">[4]</xref>
###xml 804 807 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Trop1">[5]</xref>
###xml 549 554 <span type="species:ncbi:9606">women</span>
###xml 593 602 <span type="species:ncbi:1280">S. aureus</span>
Superantigens, especially toxic shock syndrome toxin 1 (TSST-1), are also responsible for systemic exotoxemias such as toxic shock syndrome (TSS), an acute onset and potentially life-threatening illness. Clinical manifestations of TSS include fever, hypotension, rash, desquamation, and multi-organ failure. These symptoms are the result of overwhelming cytokine production systemically due to abnormal cross-linkage between T cells and macrophages by superantigens. The most recognized cases of TSS are associated with tampon usage in menstruating women; however, TSS is also associated with S. aureus infections at surgical or skin infection sites [2], [4]. Bacterial contamination of wound dressings, in particular occlusive dressings, have been suggested as the source of infection in some TSS cases [5].
###end p 10
###begin p 11
###xml 50 59 50 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 194 203 194 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Tenover1">[6]</xref>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tst</italic>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Limbago1">[7]</xref>
###xml 696 705 696 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 837 840 837 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Limbago1">[7]</xref>
###xml 842 845 842 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Moran1">[8]</xref>
###xml 50 59 <span type="species:ncbi:1280">S. aureus</span>
###xml 194 203 <span type="species:ncbi:1280">S. aureus</span>
###xml 205 209 <span type="species:ncbi:1280">MSSA</span>
###xml 696 705 <span type="species:ncbi:1280">S. aureus</span>
###xml 707 711 <span type="species:ncbi:1280">MRSA</span>
Based on pulsed-field gel electrophoresis (PFGE), S. aureus strains can be grouped into several clonal types. In the United States, USA200 PFGE type were the most common methicillin susceptible S. aureus (MSSA) isolates recovered from national nasal colonization studies [6]. USA200 clonal type, which is genetically similar to the epidemic hospital strain EMRSA16 in the United Kingdom, is also the major clonal type associated with TSS, presumably due to the high prevalence of these isolates to possess tst (the gene for TSST-1). USA300 and USA400 clonal types have been associated recently with necrotizing pneumonia and necrotizing fasciitis in community settings [7]. Methicillin resistant S. aureus (MRSA) USA300 has emerged as one of the major causes of invasive staphylococcal infections in both community and hospital settings [7], [8].
###end p 11
###begin p 12
###xml 219 222 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-DeBels1">[9]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert1">[11]</xref>
###xml 312 321 312 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 549 553 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Stevens2">[12]</xref>
###xml 571 580 568 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 790 799 787 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 824 833 821 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 312 321 <span type="species:ncbi:1280">S. aureus</span>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
###xml 544 548 <span type="species:ncbi:1280">MRSA</span>
###xml 571 580 <span type="species:ncbi:1280">S. aureus</span>
###xml 790 799 <span type="species:ncbi:1280">S. aureus</span>
###xml 824 833 <span type="species:ncbi:1280">S. aureus</span>
Protein-synthesis inhibitors, such as clindamycin and linezolid inhibit TSST-1 production at sub-growth inhibitory concentrations, and the suppression is associated with improved clinical responses in patients with TSS [9]-[11]. However, these antibiotics are often recommended for treating antibiotic resistant S. aureus infections, and not for TSS prophylaxis. On the other hand, beta-lactam antibiotics induce or increase TSST-1 production, which may increase the risk of TSS in patients with severe staphylococcal infections, especially by MRSA [12]. Given that most S. aureus infections are initiated at mucosal and skin sites, topical anti-staphylococcal agents, that can be incorporated into wound dressings, disposable medical devices, or tampons to inhibit toxin production and/or S. aureus growth and thus prevent S. aureus infections or TSS, would have clinical value.
###end p 12
###begin p 13
###xml 382 391 382 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 417 421 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 462 471 459 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 504 509 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 516 520 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Ruzin1">[13]</xref>
###xml 521 525 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert2">[15]</xref>
###xml 637 646 630 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 751 755 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Peterson1">[16]</xref>
###xml 757 761 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert3">[17]</xref>
###xml 883 887 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert4">[18]</xref>
###xml 1037 1041 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Li1">[19]</xref>
###xml 1099 1108 1088 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1134 1143 1123 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1192 1196 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Ruzin1">[13]</xref>
###xml 1198 1202 1187 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert2">[15]</xref>
###xml 1402 1411 1391 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1517 1521 1506 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-McNamara1">[20]</xref>
###xml 1523 1527 1512 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Brissette1">[21]</xref>
###xml 1669 1689 1658 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterococcus faecium</italic>
###xml 1694 1714 1683 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus mutans</italic>
###xml 1800 1804 1789 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Brissette1">[21]</xref>
###xml 1805 1809 1794 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Haynes1">[25]</xref>
###xml 1839 1848 1828 1837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1935 1939 1924 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-McNamara1">[20]</xref>
###xml 382 391 <span type="species:ncbi:1280">S. aureus</span>
###xml 462 471 <span type="species:ncbi:1280">S. aureus</span>
###xml 637 646 <span type="species:ncbi:1280">S. aureus</span>
###xml 710 717 <span type="species:ncbi:9986">rabbits</span>
###xml 965 968 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 1099 1108 <span type="species:ncbi:1280">S. aureus</span>
###xml 1134 1143 <span type="species:ncbi:1280">S. aureus</span>
###xml 1402 1411 <span type="species:ncbi:1280">S. aureus</span>
###xml 1669 1689 <span type="species:ncbi:1352">Enterococcus faecium</span>
###xml 1694 1714 <span type="species:ncbi:1309">Streptococcus mutans</span>
###xml 1839 1848 <span type="species:ncbi:1280">S. aureus</span>
Glycerol monolaurate (GML) (2,3-dihydroxypropyl dodecanoate) is a lauric acid glycerol ester commonly used in the food and cosmetic industries as an emulsifier and preservative and is generally recognized as safe (GRAS) by the Food and Drug Administration for topical use at doses up to 100 mg/ml. GML interferes with membrane signal transduction and thereby inhibits the growth of S. aureus, blocks the induction of beta-lactamase, and delays the production of S. aureus exoproteins, such as TSST-1 and alpha-toxin [13]-[15]. GML also reduces the production of proinflammatory cytokines and chemokines by mammalian cells in response to S. aureus and purified TSST-1 (100 microg/ml), and prevents lethality in rabbits challenged vaginally with TSST-1 [16], [17]. Given these properties, GML has been tested as a tampon additive and reduces staphylococcal exotoxin production in vivo [18]. In addition, GML (5% gel) has been demonstrated recently to prevent vaginal SIV transmission in monkeys by inhibiting innate inflammatory responses [19]. The compound, however, is not stable in the presence of S. aureus and can be hydrolyzed by S. aureus esterase (lipase) into glycerol and lauric acid [13], [15]. To overcome the limitation of inactivation, compounds with ether linkage have been suggested as potential alternatives to GML. Many of these ether compounds inhibit TSST-1 production in addition to S. aureus growth, and they are more stable than ester compounds (such as GML) to chemical and enzymatic hydrolysis [20], [21]. 1-O-Dodecyl-rac-glycerol (DDG) (3-(dodecyloxy)propane-1,2-diol) is the corresponding alkylglycerol ether to GML. DDG inhibits the growth of Enterococcus faecium and Streptococcus mutans primarily by stimulating autolysin activity and interfering with cell wall synthesis [21]-[25]. DDG simultaneously inhibits S. aureus growth and TSST-1 production, but the mechanisms of action has not been characterized [20].
###end p 13
###begin p 14
###xml 168 177 168 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 339 348 339 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 504 513 504 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 168 177 <span type="species:ncbi:1280">S. aureus</span>
###xml 339 348 <span type="species:ncbi:1280">S. aureus</span>
###xml 504 513 <span type="species:ncbi:1280">S. aureus</span>
Given the structural similarity of GML and DDG and its supposed stability to lipase degradation over GML, DDG was hypothesized to be more potent than GML at inhibiting S. aureus growth and TSST-1 production, and therefore a better antistaphylococcal agent candidate than GML. Our goal was to compare the efficacy of these two compounds on S. aureus growth, and TSST-1 production in vitro and in vivo. We also studied in vivo the interactions between host innate immune responses and the compounds during S. aureus infection.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 18 27 18 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 18 27 <span type="species:ncbi:1280">S. aureus</span>
Stability against S. aureus enzymes
###end title 16
###begin p 17
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 278 284 270 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g001">Fig. 1</xref>
###xml 575 584 557 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 55 64 <span type="species:ncbi:1280">S. aureus</span>
###xml 575 584 <span type="species:ncbi:1280">S. aureus</span>
###xml 585 588 <span type="species:ncbi:1280">MN8</span>
GML- and DDG-containing agarose slides were exposed to S. aureus overnight cultures to determine the stability of the compounds to lipase contained in the culture supernates. A clear zone was observed on the GML 500 microg/ml agarose slide, but not the DDG 500 microg/ml slide (Fig. 1). The solubility limit of GML in aqueous solutions at 37degreesC is approximately 100 microg/ml, and thus the zone of clearance, reflecting GML degradation by lipase, can be observed in the presence of a turbid background. The observation indicated that DDG was resistant to degradation by S. aureus MN8 lipase, while GML was not resistant to lipase.
###end p 17
###begin title 18
###xml 30 51 30 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 30 51 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 53 56 <span type="species:ncbi:1280">MN8</span>
Stability of the compounds to Staphylococcus aureus (MN8) lipase.
###end title 18
###begin p 19
(A) Glycerol monolaurate (GML). (B) Dodecylglycerol (DDG). Clear zone indicates that the compound was degraded. Arrow denotes of the radius of the clear zone on the slide.
###end p 19
###begin title 20
In vitro growth inhibition
###end title 20
###begin p 21
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 597 598 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 646 652 626 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g002">Fig. 2</xref>
###xml 932 938 904 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g003">Fig. 3</xref>
###xml 1026 1035 998 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 55 64 <span type="species:ncbi:1280">S. aureus</span>
###xml 154 158 <span type="species:ncbi:1280">MSSA</span>
###xml 167 171 <span type="species:ncbi:1280">MRSA</span>
###xml 180 184 <span type="species:ncbi:1280">MRSA</span>
###xml 193 197 <span type="species:ncbi:1280">MSSA</span>
###xml 206 210 <span type="species:ncbi:1280">MRSA</span>
###xml 249 254 <span type="species:ncbi:9606">women</span>
###xml 274 281 <span type="species:ncbi:9606">persons</span>
###xml 1026 1035 <span type="species:ncbi:1280">S. aureus</span>
###xml 1286 1290 <span type="species:ncbi:1280">MSSA</span>
###xml 1295 1299 <span type="species:ncbi:1280">MRSA</span>
###xml 1392 1396 <span type="species:ncbi:1280">MRSA</span>
###xml 1438 1442 <span type="species:ncbi:1280">MSSA</span>
###xml 1586 1590 <span type="species:ncbi:1280">MSSA</span>
###xml 1595 1599 <span type="species:ncbi:1280">MRSA</span>
###xml 1761 1765 <span type="species:ncbi:1280">MRSA</span>
The differences in susceptibility to GML and DDG among S. aureus strains were evaluated broadly using a large collection of clinically relevant isolates (MSSA USA200, MRSA USA200, MRSA USA300, MSSA USA400, MRSA USA400, vaginal isolates from healthy women, and isolates from persons with atopic dermatitis). Growth inhibitory effects of GML (50, 100, and 500 microg/ml) and DDG (25, 50, and 100 microg/ml) were examined at 18 h. In general, GML was bacteriostatic at concentrations of 50 microg/ml and 100 microg/ml, and was bactericidal (3 log decrease in CFU/ml from the starting inoculum of 1x107 CFU/ml) at the concentration of 500 microg/ml (Fig. 2). On the other hand, DDG had a bacteriostatic effect on most strain categories at the concentration of 25 microg/ml (one dilution lower than GML). As the concentrations of DDG increased from 25 to 50 and 100 microg/ml, bacterial densities decreased an additional 1-2 log CFU/ml (Fig. 3). Overall, DDG was consistently more effective in preventing bacteria growth among all S. aureus strain categories, including vaginal and atopic dermatitis strains, than GML at concentrations of 50 and 100 microg/ml (p<0.01 for comparisons of GML and DDG against all 54 strains at both concentrations). There was no significant difference between MSSA and MRSA in response to GML (p = 0.79 and 0.12 for GML 50 and 100 microg/ml, respectively); However, MRSA apear to be more susceptible to DDG than MSSA at the concentrations 50 and 100 microg/ml (p = 0.01 and p<0.01, respectively). Some clonal variability was noted among strains, where USA400 (MSSA and MRSA) strains were relatively more resistant to DDG and the high dose of GML (500 microg/ml) than other clonal types (USA300 and USA200) tested. Community-associated MRSA USA300 strains were the most susceptible clonal type to DDG.
###end p 21
###begin title 22
###xml 41 62 41 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 41 62 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Glycerol monolaurate (GML) inhibition of Staphylococcus aureus.
###end title 22
###begin p 23
###xml 65 74 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 65 74 <span type="species:ncbi:1280">S. aureus</span>
###xml 118 122 <span type="species:ncbi:1280">MRSA</span>
###xml 135 139 <span type="species:ncbi:1280">MSSA</span>
###xml 152 156 <span type="species:ncbi:1280">MRSA</span>
###xml 169 173 <span type="species:ncbi:1280">MRSA</span>
###xml 186 190 <span type="species:ncbi:1280">MSSA</span>
###xml 256 261 <span type="species:ncbi:9606">women</span>
GML concentrations 50, 100, and 500 microg/ml were tested versus S. aureus isolates from different PFGE types, USA400 MRSA (A), USA400 MSSA (B), USA300 MRSA (C), USA200 MRSA (D), USA200 MSSA (E), atopic dermatitis strains (F), vaginal strains from healthy women (G), for 18 h at 37degreesC with shaking. The dashed line indicates the starting inocula. Each square (blacksquare, square, filled) indicates one isolate. The bars represent the mean+/-SEM of bacterial density in the group.
###end p 23
###begin title 24
###xml 36 57 36 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 36 57 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Dodecylglycerol (DDG) inhibition of Staphylococcus aureus.
###end title 24
###begin p 25
###xml 64 73 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 64 73 <span type="species:ncbi:1280">S. aureus</span>
###xml 117 121 <span type="species:ncbi:1280">MRSA</span>
###xml 134 138 <span type="species:ncbi:1280">MSSA</span>
###xml 151 155 <span type="species:ncbi:1280">MRSA</span>
###xml 168 172 <span type="species:ncbi:1280">MRSA</span>
###xml 185 189 <span type="species:ncbi:1280">MSSA</span>
###xml 255 260 <span type="species:ncbi:9606">women</span>
DDG concentrations 25, 50, and 100 microg/ml were tested versus S. aureus isolates from different PFGE types, USA400 MRSA (A), USA400 MSSA (B), USA300 MRSA (C), USA200 MRSA (D), USA200 MSSA (E), atopic dermatitis strains (F), vaginal strains from healthy women (G), for 18 h at 37degreesC with shaking. The dashed line indicates the starting inocula. Each triangle (black triangle) indicates one isolate. The bars represent the mean+/-SEM of bacterial density in the group.
###end p 25
###begin title 26
In vitro TSST-1 suppression
###end title 26
###begin p 27
###xml 95 104 95 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 385 392 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g004">Fig. 4A</xref>
###xml 567 574 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g004">Fig. 4B</xref>
###xml 669 676 649 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g004">Fig. 4C</xref>
###xml 824 831 800 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g004">Fig. 4D</xref>
###xml 95 104 <span type="species:ncbi:1280">S. aureus</span>
###xml 105 108 <span type="species:ncbi:1280">MN8</span>
###xml 625 628 <span type="species:ncbi:1280">MN8</span>
###xml 731 734 <span type="species:ncbi:1280">MN8</span>
To evaluate toxin inhibitory effects of the compounds at sub-growth-inhibition concentrations, S. aureus MN8 was tested for growth inhibition and the corresponding TSST-1 production by GML (25 and 50 microg/ml) and DDG (5, 15, and 25 microg/ml) at 6 and 24 h. GML (25 and 50 microg/ml) inhibited bacterial growth at 6 h, however, this bacteriostatic effect was no longer seen by 24 h (Fig. 4A). TSST-1 level was significantly reduced by GML at 25 and 50 microg/ml at 6 h (>99% reduction), and this effect persisted through 24 h (49% and 78% reduction, respectively) (Fig. 4B). DDG (5 microg/ml) did not inhibit the growth of MN8, and did not inhibit TSST-1 production (Fig. 4C). However, DDG (15 microg/ml) inhibited the growth of MN8 at 6 h but not 24 h, and TSST-1 production was inhibited by >99% at 6 h and 61% at 24 h (Fig. 4D). The results indicated that GML delayed TSST-1 production independent of growth inhibition, while DDG inhibition of toxin production was dependent on bacterial growth inhibition.
###end p 27
###begin title 28
###xml 26 47 26 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 26 47 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Effects of GML and DDG on Staphylococcus aureus Toxic Shock Syndrome Toxin-1 (TSST-1) production.
###end title 28
###begin p 29
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 227 236 223 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 479 486 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 4 13 <span type="species:ncbi:1280">S. aureus</span>
###xml 14 17 <span type="species:ncbi:1280">MN8</span>
###xml 227 236 <span type="species:ncbi:1280">S. aureus</span>
###xml 237 240 <span type="species:ncbi:1280">MN8</span>
(A) S. aureus MN8 was exposed to GML 0, 25 and 50 microg/ml for 6 and 24 h, and bacterial densities at 6 and 24 h were determined by plate counts. (B) The corresponding concentrations of TSST-1 of the above GML experiment. (C) S. aureus MN8 was exposed to DDG 0, 5, 15, and 25 microg/ml for 6 and 24 h. (D) The corresponding concentrations of TSST-1 from above DDG experiments. TSST-1 concentrations are presented as percent of the TSST-1 concentrations in 24 h control samples. Results are mean+/-SEM. The dashed line indicates the starting inocula. *, p<0.05.
###end p 29
###begin title 30
Mammalian cell toxicity
###end title 30
###begin p 31
###xml 182 184 182 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 376 378 376 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 499 501 491 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 563 569 547 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g005">Fig. 5</xref>
###xml 674 676 658 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 217 222 <span type="species:ncbi:9606">human</span>
Since GML and DDG are most likely to be utilized in topical applications, they will be in contact with epithelial cells. Therefore, we determined the toxicity (median lethal dose, LD50) of GML and DDG to immortalized human vaginal epithelial cells (HVECs) using an assay to measure the membrane integrity (lactate dehydrogenase [LDH] release) following 6 h incubations. The LD50 of GML for a monolayer of confluent HVECs was 83 microg/ml (95% confidence interval [CI]: 69-99 microg/ml), while the LD50 of DDG for HVECs was 50 microg/ml (95% CI: 43-62 microg/ml) (Fig. 5). These results indicated that DDG was statistically more toxic to HVECs than GML. However, since the LD50 concentrations of DDG were lower than its bacterial growth inhibition concentrations in vitro, the compound may still be useful as an antistaphylococcal agent.
###end p 31
###begin title 32
###xml 31 36 <span type="species:ncbi:9606">Human</span>
Cytotoxicity of GML and DDG to Human Vaginal Epithelial Cells (HVECs).
###end title 32
###begin p 33
###xml 219 221 180 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
HVECs were exposed to GML (blacksquare, square, filled) and DDG (black triangle) for 6 h. Cytotoxicity was accessed by measuring the release of LDH. Error bars are SEM. The dashed line indicates median cell survival (LD50). Symbols:blacksquare, square, filled, GML; black triangle, DDG.
###end p 33
###begin title 34
###xml 8 14 <span type="species:ncbi:9986">rabbit</span>
In vivo rabbit Wiffle ball infection model
###end title 34
###begin p 35
###xml 264 285 264 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Yarwood1">[26]</xref>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Scott1">[27]</xref>
###xml 664 671 664 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g006">Fig. 6A</xref>
###xml 803 812 803 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 823 824 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 138 144 <span type="species:ncbi:9986">rabbit</span>
###xml 677 684 <span type="species:ncbi:9986">rabbits</span>
###xml 803 812 <span type="species:ncbi:1280">S. aureus</span>
###xml 814 817 <span type="species:ncbi:1280">MN8</span>
###xml 842 849 <span type="species:ncbi:9986">rabbits</span>
###xml 874 881 <span type="species:ncbi:9986">rabbits</span>
###xml 941 947 <span type="species:ncbi:9986">rabbit</span>
###xml 1008 1014 <span type="species:ncbi:9986">rabbit</span>
###xml 1059 1066 <span type="species:ncbi:9986">rabbits</span>
Both GML and DDG demonstrated in vitro potential as topical anti-staphylococcal agents, thus their efficacy in vivo was evaluated using a rabbit Wiffle ball infection model with compound (1 mg/ml, every-other-day) injected directly into the site of infection [see Materials and Methods]. This model is a model for toxic shock syndrome (TSS) as the bacteria are localized in the Wiffle ball both in suspension and as biofilms formed along the Wiffle ball surface; however, superantigens penetrate the Wiffle ball encapsulation tissue into blood circulation to cause systemic effects, including TSS [26], [27]. The survival curves for these experiments are shown in Fig. 6A. All rabbits in the control group (N = 5) died by day 4 (3 on day 2 and 2 on day 4) following inoculation of the Wiffle balls with S. aureus (MN8) 3x108 CFU/ml. Two of 5 rabbits in DDG group and 4 of 5 rabbits in GML group were alive by the end of the 7 day study. One rabbit in DDG group died on day 2, 1 on day 4, and 1 on day 7; one rabbit in GML group died on day 2. The survival of rabbits receiving GML (4/5) was statistically better than the control (0/5) group (p<0.05, Fisher exact).
###end p 35
###begin title 36
###xml 47 53 <span type="species:ncbi:9986">rabbit</span>
Antistaphylococcal effects of GML and DDG in a rabbit Wiffle ball infection model.
###end title 36
###begin p 37
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 62 71 62 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 0 7 <span type="species:ncbi:9986">Rabbits</span>
###xml 62 71 <span type="species:ncbi:1280">S. aureus</span>
###xml 72 75 <span type="species:ncbi:1280">MN8</span>
###xml 178 185 <span type="species:ncbi:9986">rabbits</span>
###xml 226 233 <span type="species:ncbi:9986">rabbits</span>
###xml 404 411 <span type="species:ncbi:9986">rabbits</span>
Rabbits (n = 5 in each group) were infected with 3x108 CFU/ml S. aureus MN8, and compounds (final concentration 1 mg/ml) were instilled into the Wiffle balls every-other-day and rabbits monitored up to 7 days. Survival of the rabbits (A), bacterial counts (B), TSST-1 production (C), and TNF-alpha levels (D) in the Wiffle balls. TSST-1 presented as percent of day 2 TSST-1 concentrations of the control rabbits (GML, close bars; DDG, open bars). Error bars are SEM. Symbols: o, control; blacksquare, square, filled, GML; black triangle, DDG; *, p<0.05.
###end p 37
###begin p 38
###xml 531 540 527 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 546 567 542 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pasteurella multocida</italic>
###xml 275 282 <span type="species:ncbi:9986">rabbits</span>
###xml 295 302 <span type="species:ncbi:9986">rabbits</span>
###xml 531 540 <span type="species:ncbi:1280">S. aureus</span>
###xml 546 567 <span type="species:ncbi:747">Pasteurella multocida</span>
###xml 617 623 <span type="species:ncbi:9986">rabbit</span>
###xml 647 653 <span type="species:ncbi:9986">rabbit</span>
The Wiffle ball infection model provides the opportunity to study the interactions among bacteria, host innate immune responses, and therapeutic compounds by taking repeated samples at the infection site over time. We had difficulty obtaining fluids from Wiffle balls in two rabbits (one of the rabbits in GML and one in DDG group).Thus, the sample analyses, including bacterial counts, TNF-alpha (as a biomarker for TSS), and TSST-1 levels, were based on available sample points. All Wiffle ball sample fluids uniformly contained S. aureus, but Pasteurella multocida, was recovered from a sample taken on day 2 of a rabbit in the DDG group. That rabbit died at day 4.
###end p 38
###begin p 39
###xml 170 177 170 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g006">Fig. 6B</xref>
One day after initial dosing, bacterial counts in the DDG treatment group were 0.65 and 1 log lower than those in the GML treatment and the control groups, respectively (Fig. 6B). However, in spite of the repeated dosing, bacterial counts in DDG group increased over time. In contrast, GML suppressed bacterial growth throughout the 7 day study period. Neither compound was able to achieve >3 log reduction in bacterial load within the Wiffle ball at the concentration tested.
###end p 39
###begin p 40
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g006">Fig. 6C</xref>
###xml 77 84 <span type="species:ncbi:9986">rabbits</span>
###xml 113 120 <span type="species:ncbi:9986">rabbits</span>
###xml 207 214 <span type="species:ncbi:9986">rabbits</span>
###xml 359 366 <span type="species:ncbi:9986">rabbits</span>
TSST-1 concentrations within the Wiffle ball cavities of GML and DDG treated rabbits were lower than the control rabbits (Fig. 6C). On day 2, TSST-1 was significantly inhibited by 60% and 66% of the control rabbits for GML and DDG, respectively (p<0.001, both treatments). On day 7, TSST-1 in the GML group remained significantly lower than TSST-1 in control rabbits on day 2 (58% reduction, p<0.05), while the level in DDG group was not significantly lower than controls on day 2 (22% reduction).
###end p 40
###begin p 41
###xml 139 146 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007499-g006">Fig. 6D</xref>
###xml 59 66 <span type="species:ncbi:9986">rabbits</span>
###xml 184 191 <span type="species:ncbi:9986">rabbits</span>
###xml 297 304 <span type="species:ncbi:9986">rabbits</span>
###xml 575 582 <span type="species:ncbi:9986">rabbits</span>
###xml 771 777 <span type="species:ncbi:9986">rabbit</span>
###xml 847 854 <span type="species:ncbi:9986">rabbits</span>
Baseline TNF-alpha levels in the Wiffle ball fluids of all rabbits were below the lower limit of detection (200 pg/ml) prior to infection (Fig. 6D). One day after bacterial challenge, rabbits treated with GML showed significantly lower concentrations of TNF-alpha in the Wiffle ball cavities than rabbits in control and DDG treatment groups: TNF-alpha average concentrations increased to 32.8 ng/ml (range: 11.6-61.9 ng/ml), 7.9 ng/ml (range: 1.8-17.7 ng/ml), and 18.6 ng/ml (range: 3.1-95.9 ng/ml) for control, GML, and DDG groups, respectively. TNF-alpha concentrations of rabbits in the GML group remained low throughout the period of study (4.1 ng/ml; range: 3.0-5.5 ng/ml). On the other hand, there was wide variation in TNF-alpha in the DDG group. TNF-alpha in one rabbit decreased from 26.9 ng/ml on day 1 to 14.7 ng/ml on day 7, but other rabbits in this group had increasing TNF-alpha levels throughout the experiment. Overall, there is no strong evidence indicating DDG's ability to modulate innate immune responses.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 33 42 33 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-McCormick1">[28]</xref>
###xml 291 300 291 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-McNamara1">[20]</xref>
###xml 392 401 392 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Kitahara1">[29]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Kabara1">[30]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert4">[18]</xref>
###xml 963 972 963 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Ruzin1">[13]</xref>
###xml 1205 1214 1205 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 33 42 <span type="species:ncbi:1280">S. aureus</span>
###xml 291 300 <span type="species:ncbi:1280">S. aureus</span>
###xml 392 401 <span type="species:ncbi:1280">S. aureus</span>
###xml 963 972 <span type="species:ncbi:1280">S. aureus</span>
###xml 1205 1214 <span type="species:ncbi:1280">S. aureus</span>
###xml 1618 1624 <span type="species:ncbi:9986">rabbit</span>
TSS is a serious complication of S. aureus infection, and the superantigen, TSST-1, is responsible for nearly all menstrual TSS cases and at least half of non-menstrual cases [28]. Many surfactants, including fatty acids linked through ester, ether, amide, or amine bonds, appear to inhibit S. aureus growth and toxin production [20]. However, fatty acid esters and amides are susceptible to S. aureus enzyme degradation, and amines are irritable to mucous membranes [29]. Therefore, fatty acid ethers were considered to be better candidates as topical anti-staphylococcal agents. Lauric acid (a 12 carbon-containing fatty acid) was determined to be the most potent saturated fatty acid when C8 to C18 -containing fatty acids were tested against gram-positive bacteria [30]. Its ester derivative, GML, has shown excellent potential for being incorporated into tampons to reduce risk of TSS [18]. However, similar to other fatty acid esters, GML is susceptible to S. aureus lipase degradation [13]. DDG, the corresponding ether to GML, was therefore compared to GML as an anti-staphylococcal candidate to reduce the risk of TSS. The studies presented in this manuscript determined that GML and DDG inhibit S. aureus growth and toxin production, although by apparent different modes of action. In addition, a difference in strain (clonal type) specific susceptibility to both GML and DDG was observed. Overall, the studies indicated that GML is a potentially better anti-staphylococcal agent than DDG for its ability to inhibit exoprotein production regardless of effects on bacterial growth, to reduce mortality in the rabbit Wiffle ball infection model, and to cause less cytotoxicity to epithelial cells than DDG.
###end p 43
###begin p 44
###xml 68 77 68 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 136 145 136 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 220 221 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 227 228 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 244 248 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Holland1">[31]</xref>
###xml 304 313 300 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 350 351 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 391 395 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Kabara1">[30]</xref>
###xml 404 410 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 452 453 440 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 459 460 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 494 498 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Preuss1">[32]</xref>
###xml 571 580 559 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 601 605 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Kelsey1">[33]</xref>
###xml 695 704 679 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 720 724 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Holland1">[31]</xref>
###xml 1074 1083 1058 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1161 1170 1145 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1374 1383 1358 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1470 1474 1454 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Kenny1">[34]</xref>
###xml 68 77 <span type="species:ncbi:1280">S. aureus</span>
###xml 136 145 <span type="species:ncbi:1280">S. aureus</span>
###xml 304 313 <span type="species:ncbi:1280">S. aureus</span>
###xml 571 580 <span type="species:ncbi:1280">S. aureus</span>
###xml 695 704 <span type="species:ncbi:1280">S. aureus</span>
###xml 1074 1083 <span type="species:ncbi:1280">S. aureus</span>
###xml 1161 1170 <span type="species:ncbi:1280">S. aureus</span>
###xml 1374 1383 <span type="species:ncbi:1280">S. aureus</span>
A range of minimum inhibitory concentrations (MICs) for GML against S. aureus have been reported. The MICs of GML against 29 strains of S. aureus in a complex medium were reported to be between 10 to 20 microg/ml with 103 to 104 CFU/ml inocula [31]. Kabara and colleagues reported the MIC of GML against S. aureus was 25 microg/ml with approximate 107 CFU/ml inocula in trypticase soy broth [30]. Preuss et al. reported 63 microg/ml with approximate 105 to 106 CFU/mL inocula in nutrient broth [32]. Kelsey and colleagues reported the MIC of GML against three strains of S. aureus was 25-50 microg/ml [33]. The variability in MIC is potentially due to culture conditions, inoculum size, and the S. aureus strains tested [31]. By testing the compounds against a large collection of clinical relevant strains, we confirmed that there are differences in sensitivity to GML among bacterial strains, even within the same clonal type. The differences in GML sensitivity may not be solely explained by different levels of lipase produced by the strains since the differences among S. aureus clonal types can also be observed in the DDG group, which is not degraded by S. aureus lipase. We also observed that USA400 strains do not produce more lipase than USA200 strains (data not shown), despite being more resistant to the compounds. The mechanism(s) behind the differences among S. aureus clonal types in response to DDG and GML may be related to cell surface hydrophobicity [34], however, this hypothesis will need to be investigated in future studies.
###end p 44
###begin p 45
###xml 57 66 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Projan1">[14]</xref>
###xml 980 989 976 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1112 1116 1104 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert2">[15]</xref>
###xml 1152 1156 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Holland1">[31]</xref>
###xml 1236 1240 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-McNamara1">[20]</xref>
###xml 57 66 <span type="species:ncbi:1280">S. aureus</span>
###xml 980 989 <span type="species:ncbi:1280">S. aureus</span>
Although structurally similar, DDG and GML interact with S. aureus differently. Glycerol esters are commonly found in bacterial membranes, and cells have mechanisms to maintain membrane integrity in their presence. This is likely to occur also in the presence of GML. In contrast, glycerol monoethers are uncommon in bacterial membranes, and thus, the bacteria may be expected to have greater difficulty in maintenance of membrane integrity in the presence of DDG. As noted in our studies, GML antimicrobial effects were dose dependent and required higher concentrations for bactericidal activity, while DDG was predominantly bacteriostatic, but active at lower concentrations than GML. Similar mechanisms may also explain the differences between GML and DDG on toxin inhibition. GML blocks toxin induction by interfering with bacterial signal transduction on bacterial cell membranes [14]. In our study, GML (25-50 microg/ml) was able to inhibit TSST-1 production independent of S. aureus growth inhibition properties, which is in agreement with previously described results by Schlievert et al. (20 microg/ml) [15], and Holland et al. (17 microg/ml) [31]. DDG was also reported to inhibit TSST-1 production by McNamara and colleagues [20]. However, our results suggest that DDG, and likely other glycerol monoethers, inhibition of toxin production is dependent on bacterial growth inhibition, which is different from that of GML.
###end p 45
###begin p 46
###xml 136 138 136 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Johnson1">[35]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert3">[17]</xref>
###xml 356 365 356 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Weber1">[36]</xref>
###xml 155 159 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 356 365 <span type="species:ncbi:1280">S. aureus</span>
###xml 366 369 <span type="species:ncbi:1280">MN8</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
GML has a good safety profile on skin and mucosal surfaces. The compound was considered to have negative ocular irritation and have a LD50 of >20 g/kg for rats when dosed orally for 10 weeks [35]. In fact, GML (5% gel) was safe for chronic vaginal administration in monkeys over a 6 month test period [17]. In unpublished studies with year-long passage of S. aureus MN8 on sub-growth-inhibitory concentrations of GML, we observed no increase in resistance to GML's antimicrobial and anti-exotoxin effects. On the other hand, the safety of DDG in vivo has not been well studied. In one study, mice given 1 g/kg of DDG orally per day over 4 weeks indicated no signs of toxicity, and DDG was quickly absorbed and eliminated into urine [36]. Since increased doses of DDG do not enhance bacterial growth inhibition in our study, and DDG may be more irritable to mucosal surfaces than GML, minimal effective dose of DDG should be used.
###end p 46
###begin p 47
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Peterson1">[16]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Li1">[19]</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Li1">[19]</xref>
###xml 1230 1231 1226 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 843 846 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
GML has been reported to stabilize the membrane of eukaryotic cells, modulate the production of pro-inflammatory cytokines and thereby prevent the toxicity of bacterial exotoxins on eukaryotic cells [16]. We have previously suggested the benefits of GML as a dual-acting anti-infective, 1) with effects on the microbes to prevent growth and/or exotoxin production, and 2) with anti-inflammatory and membrane stabilizing effects on the host epithelial cells, which reduces the disruption in the mucosal permeability barriers caused by induction of pro-inflammatory cytokines and chemokines following infection [19]. This latter anti-inflammatory and membrane stabilizing property, although counterintuitive, may be equally important or more important than the antimicrobial effect. We reported recently that a GML (5%) containing gel prevented SIV transmission across monkey cervical and vaginal mucosa, despite mucosal surface GML concentrations being below virucidal concentrations [19]. Additionally, histological studies demonstrated an inhibitory effect on innate immunity. In our study, GML also decreased local pro-inflammatory cytokine production (as measured by TNF-alpha) despite bacterial densities of approximately 1x107 CFU/ml over 7 days.
###end p 47
###begin p 48
###xml 127 131 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Yarwood2">[37]</xref>
###xml 133 145 127 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 253 257 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert5">[38]</xref>
###xml 259 263 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Hill1">[39]</xref>
###xml 363 372 357 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 527 531 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Todd1">[40]</xref>
###xml 616 625 610 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 363 372 <span type="species:ncbi:1280">S. aureus</span>
###xml 616 625 <span type="species:ncbi:1280">S. aureus</span>
Production of TSST-1 is induced by elevated oxygen and carbon dioxide levels, neutral pH, presence of proteins, and 37degreesC [37]. Introduction of oxygen into the typically anaerobic vaginal environment may account for the tampon association with TSS [38], [39]. Although abscesses are typically perceived to be anaerobic, Todd and colleagues demonstrated that S. aureus abscesses are aerobic, and appear to provide TSST-1 stimulating environmental conditions, similar to those occurring vaginally in the presence of tampons [40]. The Wiffle ball infection model as used in this study has aspects of both types of S. aureus infections included in an aerobic encapsulated abscess, which has internal surfaces similar to the vaginal mucosa. As bacteria were encapsulated in the Wiffle ball, the model provided an ideal environment for real-time monitoring of the interactions among the host innate immune response, bacteria, and treatments (DDG and GML) at the infection site.
###end p 48
###begin p 49
###xml 181 190 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 181 190 <span type="species:ncbi:1280">S. aureus</span>
Based on the collective results of this study, GML is proposed as more effective anti-staphylococcal topical anti-infective candidate than DDG, despite its potential degradation by S. aureus lipase.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
S. aureus isolates
###end title 51
###begin p 52
###xml 106 115 106 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Klevens1">[41]</xref>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Fey1">[42]</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Klevens1">[41]</xref>
###xml 1056 1065 1056 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 106 115 <span type="species:ncbi:1280">S. aureus</span>
###xml 161 165 <span type="species:ncbi:1280">MSSA</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 342 346 <span type="species:ncbi:1280">MRSA</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 499 503 <span type="species:ncbi:1280">MRSA</span>
###xml 532 536 <span type="species:ncbi:1280">MSSA</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
###xml 671 675 <span type="species:ncbi:1280">MRSA</span>
###xml 708 712 <span type="species:ncbi:1280">MSSA</span>
###xml 923 927 <span type="species:ncbi:1280">MRSA</span>
###xml 1056 1065 <span type="species:ncbi:1280">S. aureus</span>
###xml 1184 1189 <span type="species:ncbi:9606">women</span>
###xml 1250 1258 <span type="species:ncbi:9606">patients</span>
Fifty-four clinical isolates were tested to assess the ability of GML versus DDG to inhibit the growth of S. aureus. These included 10 menstrual vaginal TSST-1+ MSSA isolates within the pulsed-field gel electrophoresis (PFGE) type USA200 as defined by the CDC [41]. These isolates were from TSS patients across the United States. Ten TSST-1+ MRSA isolates were included within PFGE type USA200, and all of these isolates were from Minnesota, with 6 from patients with TSS. Five isolates were USA400 MRSA, and 5 isolates were USA400 MSSA. All USA400 isolates were from patients with necrotizing pneumonia, purpura fulminans, or non-menstrual TSS [42]. Three of the USA400 MRSA and three of the USA400-related MSSA isolates made the superantigen staphylococcal enterotoxin C (SEC), and two in each group made SEB. All ten isolates were positive for Panton-Valentine leukocidin (PVL). Four isolates were categorized as USA300 MRSA and were positive for the superantigen enterotoxin-like Q and made PVL [41]. Since GML and DDG are likely to be used topically, S. aureus derived from both skin and mucous membranes were also evaluated. Vaginal isolates (N = 10) were obtained from healthy women during menstruation, and 10 skin strains were obtained from patients with atopic dermatitis. These 20 isolates were not further characterized with respect to exotoxin production or methicillin susceptibility. Collectively, these 54 clinical isolates were isolated from 1995 to 2007 and are maintained in the Schlievert and Peterson laboratories in the lyophilized state as low passage cultures.
###end p 52
###begin p 53
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Projan1">[14]</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert2">[15]</xref>
###xml 0 9 <span type="species:ncbi:1280">S. aureus</span>
###xml 10 13 <span type="species:ncbi:1280">MN8</span>
###xml 26 30 <span type="species:ncbi:1280">MSSA</span>
###xml 240 246 <span type="species:ncbi:9986">rabbit</span>
S. aureus MN8 is a USA200 MSSA clinical isolate whose growth and exotoxin responses to GML have been reported previously [14], [15]. Therefore, this strain was chosen to evaluate exotoxin inhibitory ability of the compounds and used in the rabbit Wiffle ball infection study.
###end p 53
###begin title 54
Antimicrobial compounds
###end title 54
###begin p 55
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
DDG (racemic 1-O-dodecylglycerol; CAS registry number: 1561-07-5; 3-(dodecyloxy)propane-1,2-diol; Alexis Corporation, Laufeltinger, Switzerland), and glycerol monolaurate (GML) (Monomuls 90-L12; CAS registry number: 142-18-7; 2,3-dihydroxypropyl dodecanoate; Cognis, Cincinnati, Ohio) were prepared as high concentration stocks. GML was dissolved in ethanol, and DDG was dissolved in dimethyl sulfoxide (DMSO), as recommended by the manufacturers.
###end p 55
###begin title 56
Determination of compound degradation by bacterial lipase
###end title 56
###begin p 57
###xml 10 19 10 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 372 376 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert2">[15]</xref>
###xml 10 19 <span type="species:ncbi:1280">S. aureus</span>
###xml 21 24 <span type="species:ncbi:1280">MN8</span>
Overnight S. aureus (MN8) culture supernates (20 microl) were filtered to remove bacteria and placed into wells on agarose slides incorporated with either GML or DDG (500 microg/ml) and incubated for 5 h at 37degreesC and degradation of compound was assessed visually by measuring zone of clearing. The method for preparing these slides was adapted from Schlievert et al. [15].
###end p 57
###begin title 58
Culture conditions
###end title 58
###begin p 59
###xml 238 239 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 734 736 718 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 749 758 733 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1173 1177 1153 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Pankey1">[43]</xref>
###xml 476 481 <span type="species:ncbi:9940">sheep</span>
###xml 749 758 <span type="species:ncbi:1280">S. aureus</span>
###xml 759 762 <span type="species:ncbi:1280">MN8</span>
Bacteria were cultured overnight in Todd-Hewitt (TH) Bacto broth (Becton Dickinson and Company, Sparks, MD) at 37degreesC with 200 revolutions per minute (RPM) shaking. Experiments were performed with approximate starting inoculum of 1x107 colony-forming units (CFU)/ml with various concentrations of GML and DDG in 1 ml of TH broth. Samples (50 microl) were serially diluted with phosphate buffered saline (PBS; Cellgro-Mediatech Inc., Herndon, VA), and spirally plated onto sheep blood agar (Becton Dickinson). Plates were incubated at 37degreesC overnight and CFU counted using aCOLyte Supercount computer software (Microbiology International, Frederick, Maryland). The lower limit of accuracy was 400 CFU/ml, approximately 2.6 log10 CFU/ml. For S. aureus MN8 experiments (6 h and 24 h), an additional 300 microl of samples were collected and frozen for TSST-1 quantification. Bactericidal activity was defined as a 99.9% (3-log10 reduction in CFU/ml) reduction in bacterial density at 18-24 h compared to the initial inoculum. The term bacteriostatic was used when bacterial growth compared to the initial inoculum was either not observed or reduced by less than 99.9% [43].
###end p 59
###begin title 60
TSST-1 Western blotting
###end title 60
###begin p 61
###xml 447 451 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Laemmli1">[44]</xref>
###xml 782 786 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert6">[45]</xref>
###xml 180 186 <span type="species:ncbi:9986">Rabbit</span>
###xml 638 644 <span type="species:ncbi:9986">rabbit</span>
Proteins in the 300 microl bacterial culture supernates were concentrated by precipitation with 4 volumes of 100% ethanol and re-suspended in 60 microl of sterile distilled water. Rabbit Wiffle ball supernate samples were not concentrated. For Western blotting, samples [1:1 mixed with Laemmli sample buffer (Bio-Rad Laboratory, Hercules, CA)] were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 12% acrylamide) [44]. After transfer to polyvinylidene fluoride membranes (Bio-Rad), the membranes were sequentially incubated with primary anti-TSST-1 (Toxin Technology. Inc., Sarasota, FL), secondary anti-rabbit IgG-alkaline phosphatase (Sigma-Aldrich), and 5-bromo 4-chloro 3-indolyl phosphate/nitroblue tetrazolium (Sigma-Aldrich) for development [45]. The relative band density was determined with ImageJ (version 1.40 g; ).
###end p 61
###begin title 62
###xml 33 38 <span type="species:ncbi:9606">human</span>
Cytotoxicity of the compounds to human vaginal cells
###end title 62
###begin p 63
###xml 619 620 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1092 1094 1078 1080 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 13 18 <span type="species:ncbi:9606">human</span>
Immortalized human vaginal epithelial cells (ATCC CRL-2616) were used to determine mammalian cell cytotoxicity of GML and DDG. The cells were maintained in Keratinocyte-Serum Free medium (KSFM, GIBCO-BRL, Grand Island, NY), supplemented with recommended supplements and antibiotics/antifungal (100 IU/ml penicillin, 100 microg/l streptomycin, and 2.5 microg/ml Fungizone). Cells were seeded into 96-well plates and grown to confluency. Cells were changed to antibiotic/antifungal-free KSFM the day before experimentation. Cells were co-incubated with compounds for 6 h at 37degreesC in a humidified incubator with 7% CO2. CytoTox-One homogenous membrane integrity assay (Promega) was used to measure the release of lactate dehydrogenase (LDH) from damaged cells as an indicator of membrane integrity. Assays were performed according to the manufacturer's instructions. Absorbances at 560 nm (excitation) and 590 nm (emission) wavelengths were measured by SpectraMax M2 microplate reader (Molecular Devices, Sunnyvale, CA). All experiments were performed in triplicate. Median lethal doses (LD50) of the compounds were the intercepts of 50% cell survival and the regression line of the two points adjacent to the values.
###end p 63
###begin title 64
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
Rabbit Wiffle ball infection model
###end title 64
###begin p 65
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Scott1">[27]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert7">[46]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007499-Schlievert3">[17]</xref>
###xml 1005 1014 1005 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1130 1139 1130 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1300 1302 1300 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1307 1316 1307 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 1452 1453 1452 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 182 188 <span type="species:ncbi:9986">rabbit</span>
###xml 357 364 <span type="species:ncbi:9986">rabbits</span>
###xml 1005 1014 <span type="species:ncbi:1280">S. aureus</span>
###xml 1130 1139 <span type="species:ncbi:1280">S. aureus</span>
###xml 1140 1143 <span type="species:ncbi:1280">MN8</span>
###xml 1307 1316 <span type="species:ncbi:1280">S. aureus</span>
###xml 1317 1320 <span type="species:ncbi:1280">MN8</span>
Ethics statement: All animal experiments were performed in accordance with protocols approved by the University of Minnesota Institutional Animal Care and Use Committee (IACUC). The rabbit Wiffle ball infection model has been previously described [27], [46]. Briefly, golf-ball-sized Wiffle balls were implanted subcutaneously in the flanks of Dutch-belted rabbits (either sex, 1.5 to 2.5 kg). The animals were allowed to recover for 6-8 weeks. On day 0 of experimentation, the animals (n = 5) received 0.3 ml of 100 mg/ml GML or DDG (or solvent control) by injection directly into the Wiffle ball (final concentration of 1 mg/ml in the 30 ml Wiffle ball). A 1 mg/ml (0.1%) final concentration for DDG and GML was chosen and hypothesized to be non-toxic and efficacious as we previously determined that a GML (5%) containing gel inserted vaginally every day in monkeys for 6 months was not toxic [17]; and initial in vitro results indicated this concentration of GML and DDG would be bactericidal against S. aureus and inhibit TSST-1 production. The same treatments were administered every other day (days 2, 4, and 6). Overnight S. aureus MN8 cultures were grown in TH broth, washed once with PBS, and re-suspended to the desired concentration in PBS. Immediately after injecting the compounds, 1x1010 CFU S. aureus MN8 (in a volume of 1.0 ml) was injected into each animal's Wiffle ball (30 ml), bringing the local concentration to approximately 3x108 CFU/ml. Animals were monitored daily for signs of TSS, including fever (with use of rectal thermometers), diarrhea, weight loss, and moribundity (as an indication of imminent death). A small volume of fluid (0.3 ml) was drawn from each Wiffle ball daily for bacterial counts, TSST-1 measurement, and TNF-alpha determination. Animals were euthanized on day 7.
###end p 65
###begin title 66
Tumor necrosis factor alpha (TNF-alpha) ELISA
###end title 66
###begin p 67
###xml 94 100 <span type="species:ncbi:9986">rabbit</span>
###xml 158 162 <span type="species:ncbi:9925">goat</span>
###xml 168 174 <span type="species:ncbi:9986">rabbit</span>
###xml 202 208 <span type="species:ncbi:9986">rabbit</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 237 243 <span type="species:ncbi:9986">rabbit</span>
###xml 326 332 <span type="species:ncbi:9986">Rabbit</span>
TNF-alpha was used as a biomarker of inflammation at the infection site. Purified recombinant rabbit TNF-alpha, capture antibody, primary detection antibody (goat anti-rabbit TNF-alpha), secondary anti-rabbit antibody (biotin mouse anti-rabbit TNF-alpha), and assay reagents were commercially available from Becton Dickinson. Rabbit Wiffle ball fluids were diluted a minimum of 1:2 with assay buffer to eliminate viscosity and nonspecific effects. Lower limit of detection of this assay was approximately 200 pg/ml.
###end p 67
###begin title 68
Statistical methods
###end title 68
###begin p 69
###xml 7 8 7 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 147 156 143 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 177 178 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 249 258 245 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 359 369 355 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bonferroni</italic>
###xml 387 388 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 506 507 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 147 156 <span type="species:ncbi:1280">S. aureus</span>
###xml 228 232 <span type="species:ncbi:1280">MRSA</span>
###xml 237 241 <span type="species:ncbi:1280">MSSA</span>
###xml 249 258 <span type="species:ncbi:1280">S. aureus</span>
###xml 462 468 <span type="species:ncbi:9986">rabbit</span>
Paired t-tests were performed to compare the differences in bacterial densities between GML and DDG (50 and 100 microg/ml) against the 54 clinical S. aureus isolates. Un-paired t-tests were used to compare the susceptibility of MRSA and MSSA. Total S. aureus CFU/ml and TSST-1 levels among groups were compared using one-way analysis of variance (ANOVA) with Bonferroni method to adjust p values for multiple comparisons. Fisher's exact test was used to compare rabbit survival between treatment groups. A p</=0.05 was considered statistically significant. Computations and graphing were performed using Prism version 5 (GraphPad Software, Inc. La Jolla, CA).
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
###xml 38 59 38 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 38 59 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Pathogenesis of methicillin-resistant Staphylococcus aureus infection.
###end article-title 71
###begin article-title 72
###xml 24 32 <span type="species:ncbi:9606">children</span>
Toxic shock syndrome in children: epidemiology, pathogenesis, and management.
###end article-title 72
###begin article-title 73
Atopic dermatitis.
###end article-title 73
###begin article-title 74
###xml 38 45 <span type="species:ncbi:9606">patient</span>
Toxic shock syndrome in an adult burn patient.
###end article-title 74
###begin article-title 75
###xml 37 42 <span type="species:ncbi:9606">child</span>
Toxic shock syndrome in a scald burn child treated with an occlusive wound dressing.
###end article-title 75
###begin article-title 76
###xml 20 41 20 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 20 41 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004.
###end article-title 76
###begin article-title 77
###xml 42 63 42 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 42 63 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis.
###end article-title 77
###begin article-title 78
###xml 22 31 22 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 22 31 <span type="species:ncbi:1280">S. aureus</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Methicillin-resistant S. aureus infections among patients in the emergency department.
###end article-title 78
###begin article-title 79
###xml 87 108 87 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 87 108 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis.
###end article-title 79
###begin article-title 80
Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.
###end article-title 80
###begin article-title 81
Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production.
###end article-title 81
###begin article-title 82
###xml 126 147 126 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 126 147 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
###end article-title 82
###begin article-title 83
###xml 92 113 92 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 92 113 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus.
###end article-title 83
###begin article-title 84
Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction.
###end article-title 84
###begin article-title 85
Effect of glycerol monolaurate on bacterial growth and toxin production.
###end article-title 85
###begin article-title 86
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells.
###end article-title 86
###begin article-title 87
###xml 52 66 52 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Macaca mulatta</italic>
###xml 52 66 <span type="species:ncbi:9544">Macaca mulatta</span>
Glycerol Monolaurate Does Not Alter Rhesus Macaque (Macaca mulatta) Vaginal Lactobacilli and Is Safe for Chronic Use.
###end article-title 87
###begin article-title 88
###xml 8 29 8 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 8 29 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Vaginal Staphylococcus aureus toxin production is reduced by glycerol monolaurate in tampons.
###end article-title 88
###begin article-title 89
###xml 38 41 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
Glycerol monolaurate prevents mucosal SIV transmission.
###end article-title 89
###begin article-title 90
###xml 96 117 96 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 96 117 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
###end article-title 90
###begin article-title 91
###xml 150 174 150 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus mutans BHT</italic>
###xml 150 170 <span type="species:ncbi:1309">Streptococcus mutans</span>
Studies on the antibacterial activity of dodecylglycerol. Its limited metabolism and inhibition of glycerolipid and lipoteichoic acid biosynthesis in Streptococcus mutans BHT.
###end article-title 91
###begin article-title 92
###xml 90 111 90 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus faecium</italic>
###xml 90 111 <span type="species:ncbi:1352">Streptococcus faecium</span>
Dodecylglycerol. A new type of antibacterial agent which stimulates autolysin activity in Streptococcus faecium ATCC 9790.
###end article-title 92
###begin article-title 93
###xml 37 58 37 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus faecium</italic>
###xml 37 58 <span type="species:ncbi:1352">Streptococcus faecium</span>
The involvement of the proteinase of Streptococcus faecium ATCC 9790 in the stimulation of its autolysin activity by dodecylglycerol.
###end article-title 93
###begin article-title 94
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rac</italic>
Synergism between penicillin G and the antimicrobial ether lipid, rac-1-dodecylglycerol, acting below its critical micelle concentration.
###end article-title 94
###begin article-title 95
Synergism between the antifungal agents amphotericin B and alkyl glycerol ethers.
###end article-title 95
###begin article-title 96
###xml 18 39 18 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 18 39 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo.
###end article-title 96
###begin article-title 97
###xml 20 41 20 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 20 41 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 133 140 <span type="species:ncbi:9986">rabbits</span>
Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits.
###end article-title 97
###begin article-title 98
Toxic shock syndrome and bacterial superantigens: an update.
###end article-title 98
###begin article-title 99
###xml 95 116 95 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 95 116 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus.
###end article-title 99
###begin article-title 100
Fatty acids and derivatives as antimicrobial agents.
###end article-title 100
###begin article-title 101
###xml 111 132 111 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 111 132 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.
###end article-title 101
###begin article-title 102
Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.
###end article-title 102
###begin article-title 103
###xml 52 73 52 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 52 73 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus.
###end article-title 103
###begin article-title 104
###xml 4 25 4 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 4 25 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications.
###end article-title 104
###begin article-title 105
Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate.
###end article-title 105
###begin article-title 106
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rac</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Metabolism of orally administered rac-1-O-[1'-14C]dodecylglycerol and nutritional effects of dietary rac-1-O-dodecylglycerol in mice.
###end article-title 106
###begin article-title 107
###xml 83 104 83 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 83 104 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 105 108 <span type="species:ncbi:1280">MN8</span>
Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.
###end article-title 107
###begin article-title 108
Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors.
###end article-title 108
###begin article-title 109
###xml 22 27 <span type="species:ncbi:9606">human</span>
In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses.
###end article-title 109
###begin article-title 110
Influence of focal growth conditions on the pathogenesis of toxic shock syndrome.
###end article-title 110
###begin article-title 111
###xml 53 74 53 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 53 74 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003.
###end article-title 111
###begin article-title 112
###xml 88 109 88 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 88 109 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.
###end article-title 112
###begin article-title 113
Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.
###end article-title 113
###begin article-title 114
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
###end article-title 114
###begin article-title 115
Immunochemical assays for toxic shock syndrome toxin-1.
###end article-title 115
###begin article-title 116
###xml 89 110 89 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 89 110 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 123 143 <span type="species:ncbi:36470">group A streptococci</span>
Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
###end article-title 116
###begin p 117
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: MLP has a separate research grant from 3 M for an unrelated topic. PMS and MLP have a patent application(20070276049)Regulation of Cell Membrane-Mediated effects under review.
###end p 117
###begin p 118
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a Translational Research Grant from the Academic Health Center, University of Minnesota (MLP and PMS) ; 3 M Non-tenured unrestricted faculty research award (MLP) ; and NIH research grant AI-074283 (PMS and MLP) from the National Institute of Allergy and Infectious Diseases .
###end p 118

